-
2025-521827-61-00
4
refractory/relapsed multiple myeloma
-
2025-522084-15-00
10
metastatic NSCLC patients
-
2025-522983-33-00
5
Chronic rhinosinusitis with nasal polyps
-
2025-523259-72-00
5
Hidradenitis Suppurativa (HS)
-
2025-523586-18-00
5
Non-Small Cell Lung Cancer
-
2025-523670-17-00
5
Systemic lupus erythematosus
-
2025-524316-11-00
5
Primary Progressive Multiple Sclerosis (PPMS)
-
2025-524843-11-00
4
Non-Small Cell Lung Cancer
-
2025-523431-19-00
4
2026-05-20
Idiopathic Pulmonary Fibrosis (IPF)
-
2025-522981-61-00
4
2026-05-19
endometrial cancer
-
2025-522255-25-00
5
2026-05-18
Fallopian Tube Neoplasms
-
2024-518615-19-00
5
2026-04-22
Major Depressive Disorder
-
2025-522892-27-00
4
2026-03-21
Bronchiectasis
-
2025-521314-25-00
5
2026-03-19
NPM1-m and KMT2A-r Acute Myeloid Leukemia
-
2025-521558-40-00
5
2026-02-12
Pulmonary Hypertension Associated with Interstitial Lung Disease
-
2025-521514-26-00
5
2026-01-26
Persistent, Recurrent, or Newly Diagnosed Metastatic Cervical Cancer W
-
2023-507525-42-00
5
2025-12-23
Endometrial cancer
-
2024-518899-31-00
5
2025-12-19
Variant or wild-type transthyretin (TTR) amyloid cardiomyopathy
-
2025-520982-39-00
5
2025-12-09
Philadelphia Chromosome Positive or ABL-class Philadelphia Chromosome-
-
2025-521775-31-00
5
2025-11-12
Stage IB-IIIA NSCLC Patients with uncommon EGFR Mutations
-
2023-508056-19-00
5
2025-10-02
HER2-Expressing (IHC 3+/IHC 2+), Mismatch Repair Proficient (pMMR), P
-
2024-520107-12-00
5
2025-09-03
Hidradenitis Suppurativa // Prurigo Nodularis // Vitiligo
-
2024-518589-29-00
5
2025-08-21
Bronchiectasis
-
2024-517968-36-00
5
2025-07-08
non-small cell lung cancer